Indeed, we previously demonstrated that autologous HSCT was not effective in inducing remission in T1D patients carrying high levels of circulating autoreactive CD8 and CD4 T cells, whereas low autoreactivity before Thymoglobulin therapy was associated with a good prognosis [11]. The gene discussed is CD8A; the disease is type 1 diabetes mellitus.